Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of JNJ-38518168 in Rheumatoid Arthritis Despite Methotrexate Therapy
2009-012118-27Phase 2Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing JNJ-38518168 arm with Placebo arm (2 arms). Primary endpoint: Change from baseline in DAS28 (CRP) score at Week 12. Started May 2009; status: terminated.
02
Drugs
toreforant
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-012118-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012118-27.